Epilepsy and cognition

Epilepsy and Behavior

Volumn 4, Issue SUPPL. 2, 2003, Pages

  Motamedi, Gholam ^a   Meador, Kimford ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiepileptic drug; Behavior; Cognition; Epilepsy; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CARBAMAZEPINE; CYTOCHROME P450; DIAZEPAM; DONEPEZIL; ETIRACETAM; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; NON PRESCRIPTION DRUG; OXCARBAZEPINE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PRIMIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIAGABINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AGITATION; AUDITORY HALLUCINATION; BEHAVIOR DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; EPILEPSY; GROUPS BY AGE; HUMAN; INSOMNIA; NEUROPATHOLOGY; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEIZURE; SURGICAL APPROACH; TEMPORAL LOBECTOMY; TREATMENT PLANNING; VISUAL HALLUCINATION;

EID: 0242606886     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2003.07.004     Document Type: Review

References (135)

1. Kwan P, Brodie MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001;357:216-22.
2. Meador KJ. Cognitive outcomes and predictive factors in epilepsy. Neurology 2002;58(Suppl 5):S21-6.
3. Medvedev AV. Temporal binding at gamma frequencies in the brain: paving the way to epilepsy? Australas Phys Eng Sci Med 2001;24:37-48.
4. Cho YW, Motamedi GK, Laufenbert I, et al. A Korean kindred with Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) presenting as partial seizures with mental retardation. Archives of Neurology. In press.
5. Smith DB, Craft BR, Collins J, Mattson RH, Cramer JA. Behavioral characteristics of epilepsy patients compared with normal controls. Epilepsia 1986;27:760-8.
6. Meador KJ. Cognitive effects of epilepsy and antiepileptic medications. In: Wyllie E, editor. The Treatment of Epilepsy: Principles and Practice. Philadelphia: Lippincott Williams & Willkins; 2001. p. 1215-25.
7. Jokeit H, Ebner A. Effects of chronic epilepsy on intellectual functions. Prog Brain Res 2002;135:455-63.
8. Drane DL, Meador KJ. Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 2002;3(5 Suppl):S49-53.
9. Meador KJ, Gilliam FG, Kanner AM, Pellock JM. Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 2001;2(4 Suppl):SS1-SS17.
10. Rausch R, Kraemer S, Pietras CJ, Le M, Vickrey BG, Passaro EA. Early and late cognitive changes following temporal lobe surgery for epilepsy. Neurology 2003;60:951-9.
11. Blanchette N, Smith ML. Language after temporal or frontal lobe surgery in children with epilepsy. Brain Cogn 2002;48:280-4.
12. Martin P, Maestu F, Sola RG. Effects of surgical treatment on intellectual performance and memory in a Spanish sample of drug-resistant partial onset-temporal lobe epilepsy patients. Seizure 2002;11:151-6.
13. Sinclair DB, Aronyk K, Snyder T, et al. Pediatric temporal lobectomy for epilepsy. Pediatr Neurosurg 2003;38:195-205.
14. Sillanpaa M, Jalava M, Kaleva O, Shinnar S. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998;338:1715-22.
15. Camfield C, Camfield P, Smith B, Gordon K, Dooley J. Biologic factors as predictors of social outcome of epilepsy in intellectually normal children: a population-based study. J Pediatr 1993;122:869-73.
16. Pulliainen V, Kuikka P, Jokelainen M. Motor and cognitive functions in newly diagnosed adult seizure patients before antiepileptic medication. Acta Neurol Scand 2000;101:73-8.
17. Austin JK, Dunn DW. Progressive behavioral changes in children with epilepsy. Prog Brain Res 2002;135:419-27.
18. Binnie CD. Cognitive performance, subtle seizures, and the EEG. Epilepsia 2001;42(Suppl 1):16-8.
19. Besag FM. When is it inappropriate to prescribe psychotropic medication? Epilepsia 2002;43(Suppl 2):45-50.
20. Mazzini L, Cossa FM, Angelino E, Campini R, Pastore I, Monaco F. Posttraumatic epilepsy: neuroradiologic and neuropsychological assessment of long-term outcome. Epilepsia 2003;44:569-74.
21. Huttenlocher PR, Hapke RJ. A follow-up study of intractable seizures in childhood. Ann Neurol 1990;28:699-705.
22. Dulac O. Epileptic encephalopathy. Epilepsia 2001;42(Suppl 3):23-6.
23. Umbricht D, Degreef G, Barr WB, Lieberman JA, Pollack S, Schaul N. Postictal and chronic psychoses in patients with temporal lobe epilepsy. Am J Psychiatry 1995;152:224-31.
24. Cho YW, Motamedi GK, Lesser RP, et al. Autosomal dominant nocturnal partial epilepsy (ADNPE) in a Korean kindred. Epilepsia 2001;42.
25. Helmstaedter C, Kemper B, Elger CE. Neuropsychological aspects of frontal lobe epilepsy. Neuropsychologia 1996;34:399-406.
26. Hermann B, Seidenberg M, Bell B, et al. Extratemporal quantitative MR volumetrics and neuropsychological status in temporal lobe epilepsy. J Int Neuropsychol Soc 2003;9:353-62.
27. York MK, Rettig GM, Grossman RG, et al. Seizure control and cognitive outcome after temporal lobectomy: a comparison of classic Ammon's horn sclerosis, atypical mesial temporal sclerosis, and tumoral pathologies. Epilepsia 2003;44:387-98.
28. Galanopoulou AS, Vidaurre J, Moshe SL. Under what circumstances can seizures produce hippocampal injury: evidence for age-specific effects. Dev Neurosci 2002;24:355-63.
29. Hermann B, Seidenberg M, Bell B, et al. The neurodevelopmental impact of childhood-onset temporal lobe epilepsy on brain structure and function. Epilepsia 2002;43:1062-71.
30. Bell B, Hermann B, Seidenberg M, et al. Ipsilateral reorganization of language in early-onset left temporal lobe epilepsy. Epilepsy Behav 2002;3:158-64.
31. Upton D, Thompson PJ. Age at onset and neuropsychological function in frontal lobe epilepsy. Epilepsia 1997;38:1103-13.
32. Dodrill CB. Correlates of generalized tonic-clonic seizures with intellectual, neuropsychological, emotional, and social function in patients with epilepsy. Epilepsia 1986;27:399-411.
33. O'Brien TJ, So EL, Meyer FB, Parisi JE, Jack CR. Progressive hippocampal atrophy in chronic intractable temporal lobe epilepsy. Ann Neurol 1999;45:526-9.
34. Jokeit H, Ebner A. Long term effects of refractory temporal lobe epilepsy on cognitive abilities: a cross sectional study. J Neurol Neurosurg Psychiatry 1999;67:44-50.
35. Theodore WH, Bhatia S, Hatta J, et al. Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures. Neurology 1999;52:132-6.
36. Mandelbaum DE, Burack GD. The effect of seizure type and medication on cognitive and behavioral functioning in children with idiopathic epilepsy. Dev Med Child Neurol 1997;39:731-5.
37. Berto P. Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics 2002;20:1039-59.
38. Dodrill CB. Progressive cognitive decline in adolescents and adults with epilepsy. Prog Brain Res 2002;135:399-407.
39. Duncan JS. Seizure-induced neuronal injury: human data. Neurology 2002;59(Suppl 5):S15-20.
40. Binnie CD. Cognitive effects of subclinical EEG discharges. Neurophysiol Clin 1996;26:138-42.
41. Stafstrom CE, Lynch M, Sutula TP. Consequences of epilepsy in the developing brain: implications for surgical management. Semin Pediatr Neurol 2000;7:147-57.
42. Harden CL. The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment. Neurology 2002;59(Suppl 4):S48-55.
43. Szaflarski JP, Szaflarski M, Hughes C, Ficker DM, Cahill WT, Privitera MD. Psychopathology and quality of life: psychogenic non-epileptic seizures versus epilepsy. Med Sci Monit 2003;9:CR113-8.
44. Bromfield EB, Altshuler L, Leiderman DB, et al. Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol 1992;49:617-23.
45. Kanner AM, Balabanov A. Depression and epilepsy how closely related are they? Neurology 2002;58(Suppl 5):S27-39.
46. Perini GI, Tosin C, Carraro C, et al. Interictal mood and personality disorders in temporal lobe epilepsy and juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 1996;61:601-5.
47. Alemayehu S, Bergey GK, Barry E, et al. Panic attacks as ictal manifestations of parietal lobe seizures. Epilepsia 1995;36:824-30.
48. Biraben A, Taussig D, Thomas P, et al. Fear as the main feature of epileptic seizures. J Neurol Neurosurg Psychiatry 2001;70:186-91.
49. Cramer JA, De Rue K, Devinsky O, Edrich P, Trimble MR. A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav 2003;4:124-32.
50. Smith DB. Cognitive effects of antiepileptic drugs. Adv Neurol 1991;55:197-212.
51. Drane DL, Meador KJ. Cognitive toxicity of antiepileptic drugs. In: Devinsky O, Westbrook LE. editors. Epilepsy and Developmental Disorders. Boston: Butterworth-Heinemann; 2003. p. 311-30.
52. Rutecki PA, Gidal BE. Antiepileptic drug treatment in the developmentally disabled: treatment considerations with the newer antiepileptic drugs. Epilepsy Behav 2002;3(6 Suppl 1):S24-S31.
53. Meador KJ. Cognitive side effects of antiepileptic drugs. Can J Neurol Sci 1994;21:S12-6.
54. Meador KJ, Loring DW, Huh K, Gallagher BB, King DW. Comparative cognitive effects of anticonvulsants. Neurology 1990;40:391-4.
55. Dodrill CB, Troupin AS. Neuropsychological effects of carbamazepine and phenytoin: a reanalysis. Neurology 1991;41:141-3.
56. Meador KJ, Loring DW, Moore EE, et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 1995;45:1494-9.
57. Calandre EP, Dominguez-Granados R, Gomez-Rubio M, Molina-Font JA. Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neurol Scand 1990;81:504-6.
58. Meador KJ, Loring DW, Allen ME, et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991;41:1537-40.
59. Meador KJ, Loring DW, Abney OL, et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 1993;34:153-7.
60. Scolnik D, Nulman I, Rovet J, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994;271:767-70.
61. Pulliainen V, Jokelainen M. Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients. Acta Neurol Scand 1994;89:81-6.
62. Smith Jr KR, Goulding PM, Wilderman D, Goldfader PR, Holterman-Hommes P, Wei F. Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Arch Neurol 1994;51:653-60.
63. Post RM, Ketter TA, Denicoff K, et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl) 1996;128:115-29.
64. Dimond KR, Pande AC, Lamoreaux L, Pierce MW. Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:407-17.
65. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400.
66. Lee DO, Steingard RJ, Cesena M, Helmets SL, Riviello JJ, Mikati MA. Behavioral side effects of gabapentin in children. Epilepsia 1996;37:87-90.
67. Salinsky MC, Binder LM, Oken BS, Storzbach D, Aron CR, Dodrill CB. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia 2002;43:482-90.
68. Dodrill CB, Arnett JL, Hayes AG, et al. Cognitive abilities and adjustment with gabapentin: results of a multisite study. Epilepsy Res 1999;35:109-21.
69. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999;40:1279-85.
70. Martin R, Meador K, Turrentine L, et al. Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia 2001;42:764-71.
71. Mortimore C, Trimble M, Emmers E. Effects of gabapentin on cognition and quality of life in patients with epilepsy. Seizure 1998;7:359-64.
72. Aldenkamp AP, Baker G. A systematic review of the effects of lamotrigine on cognitive function and quality of life. Epilepsy Behav 2001;2:85-91.
73. Aldenkamp AP, Arends J, Bootsma HP, et al. Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia 2002;43:19-26.
74. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-22.
75. Cohen AF, Ashby L, Crowley D, Land G, Peck AW, Miller AA. Lamotrigine (BW430C), a potential anticonvulsant: effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol 1985;20:619-29.
76. Hamilton MJ, Cohen AF, Yuen AW, et al. Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage. Epilepsia 1993;34:166-73.
77. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology 2001;56:1177-82.
78. Brown ES, Frol A, Bobadilla L, Nejtek VA, Perantie DC, Dhillon H. Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids. Psychosomatics 2003;44:204-8.
79. Neyens LG, Alpherts WC, Aldenkamp AP. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:411-9.
80. Lamberty Y, Margineanu DG, Klitgaard H. Absence of negative impact of levetiracetam on cognitive function and memory in normal and amygdala-kindled rats. Epilepsy Behav 2000;1:333-42.
81. Kossoff EH, Bergey GK, Freeman JM, Vining EP. Levetiracetam psychosis in children with epilepsy. Epilepsia 2001;42:1611-3.
82. Curran HV, Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 1993;44:529-33.
83. Aikia M, Kalviainen R, Sivenius J, Halonen T, Riekkinen PJ. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 1992;11:199-203.
84. Kalviainen R. Long-term safety of tiagabine. Epilepsia 2001;42(Suppl 3):46-8.
85. Dodrill CB, Arnett JL, Sommerville KW, Shu V. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology 1997;48:1025-31.
86. Tatum WO, French JA, Faught E, et al. Postmarketing experience with topiramate and cognition. Epilepsia 2001;42:1134-40.
87. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52:321-7.
88. Felstrom A, Blackshaw S. Topiramate for bulimia nervosa with bipolar II disorder. Am J Psychiatry 2002;159:1246-7.
89. Aldenkamp AP, Baker G, Mulder OG, et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167-78.
90. Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R. Differential cognitive and behavioral effects of topiramate and valproate. Neurology 2003;60:1483-8.
91. Dodrill CB, Arnett JL, Sommerville KW, Sussman NM. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia 1995;36:164-73.
92. Dodrill CB, Arnett JL, Sommerville KW, Sussman NM. Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy. Neurology 1993;43:2501-7.
93. McGuire AM, Duncan JS, Trimble MR. Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy. Epilepsia 1992;33:128-34.
94. Ferrie CD, Robinson RO, Panayiotopoulos CP. Psychotic and severe behavioural reactions with vigabatrin: a review. Acta Neurol Scand 1996;93:1-8.
95. Berent S, Sackellares JC, Giordani B, Wagner JG, Donofrio PD, Abou-Khalil B. Zonisamide (CI-912) and cognition: results from preliminary study. Epilepsia 1987;28:61-7.
96. Meador K. Cognitive outcomes and predictive factors in epilepsy. Neurology 2002;58(8, Suppl 5):S21-6.
97. Gabriel EM, Haglund MM. Neuropsychiatric complications after temporal lobe limbic system surgery. Neuroimaging Clin N Am 1997;7:155-64.
98. Clusmann H, Schramm J, Kral T, et al. Prognostic factors and outcome after different types of resection for temporal lobe epilepsy. J Neurosurg 2002;97:1131-41.
99. Trenerry MR, Jack Jr CR, Ivnik RJ, et al. MRI hippocampal volumes and memory function before and after temporal lobectomy. Neurology 1993;43:1800-5.
100. Loring DW, Meador KJ, Lee GP, et al. Wada memory asymmetries predict verbal memory decline after anterior temporal lobectomy. Neurology 1995;45:1329-33.
101. Griffith HR, Perlman SB, Woodard AR, et al. Preoperative FDG-PET temporal lobe hypometabolism and verbal memory after temporal lobectomy. Neurology 2000;54:1161-5.
102. Helmstaedter C, Reuber M, Elger CE. Interaction of cognitive aging and memory deficits related to epilepsy surgery. Ann Neurol 2002;52:89-94.
103. Williams J, Griebel ML, Sharp GB, Boop FA. Cognition and behavior after temporal lobectomy in pediatric patients with intractable epilepsy. Pediatr Neurol 1998;19:189-94.
104. Dlugos DJ, Moss EM, Duhaime AC, Brooks-Kayal AR. Language-related cognitive declines after left temporal lobectomy in children. Pediatr Neurol 1999;21:444-9.
105. Hoppe C, Helmstaedter C, Scherrmann J, Elger CE. No evidence for cognitive side effects after 6 months of vagus nerve stimulation in epilepsy patients. Epilepsy Behav 2001;2:351-6.
106. Hoppe C, Helmstaedter C, Scherrmann J, Elger CE. Self-reported mood changes following 6 months of vagus nerve stimulation in epilepsy patients. Epilepsy Behav 2001;2:335-42.
107. Majoie HJ, Berfelo MW, Aldenkamp AP, Evers SM, Kessels AG, Renier WO. Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome: clinical results, neuropsychological effects, and cost-effectiveness. J Clin Neurophysiol 2001;18:419-28.
108. Aldenkamp AP, Majoie HJ, Berfelo MW, et al. Long-term effects of 24-month treatment with vagus nerve stimulation on behaviour in children with Lennox-Gastaut syndrome. Epilepsy Behav 2002;3:475-9.
109. Kudo T, Yagi K. Chronological progression of a language deficit appearing to be postictally reversible in a patient with symptomatic localization-related epilepsy. Psychiatry Clin Neurosci 2000;54:131-8.
110. Jokeit H, Daamen M, Zang H, Janszky J, Ebner A. Seizures accelerate forgetting in patients with left-sided temporal lobe epilepsy. Neurology 2001;57:125-6.
111. Shulman MB, Barr W. Treatment of memory disorders in epilepsy. Epilepsy Behav 2002;3(5S):30-4.
112. Dunn DW. Neuropsychiatric aspects of epilepsy in children. Epilepsy Behav 2003;4:101-6.
113. Buelow JM, McNelis A. Should every child with epilepsy undergo a neuropsychological evaluation? Epilepsy Behav 2002;3:210-3.
114. Williams J. Learning and behavior in children with epilepsy. Epilepsy Behav 2003;4:107-11.
115. Meador KJ. Neurodevelopmental effects of antiepileptic drugs. Curr Neurol Neurosci Rep 2002;2:373-8.
116. Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002;39:251-9.
117. Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995;274:1518-25.
118. Mawer G, Clayton-Smith J, Coyle H, Kini U. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure 2002;11:512-8.
119. Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001;70:15-21.
120. Austin JK, Dunn DW, Caffrey HM, Perkins SM, Harezlak J, Rose DF. Recurrent seizures and behavior problems in children with first recognized seizures: a prospective study. Epilepsia 2002;43:1564-73.
121. Stafstrom CE. Assessing the behavioral and cognitive effects of seizures on the developing brain. Prog Brain Res 2002;135:377-90.
122. Gilliam F, Kuzniecky R, Meador K, et al. Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology 1999;53:687-94.
123. Markand ON, Salanova V, Whelihan E, Emsley CL. Health-related quality of life outcome in medically refractory epilepsy treated with anterior temporal lobectomy. Epilepsia 2000;41:749-59.
124. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58(Suppl 5):S9-20.
125. Cramer JA. Exploration of changes in health-related quality of life after 3 months of vagus nerve stimulation. Epilepsy Behav 2001;2:460-5.
126. Dodrill CB, Morris GL. Effects of vagal nerve stimulation on cognition and quality of life in epilepsy. Epilepsy Behav 2001;2:46-53.
127. Gillham R, Baker G, Thompson P, et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res 1996;24:47-55.
128. Brunbech L, Sabers A. Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents. Drugs 2002;62:593-604.
129. Vermeulen J, Aldenkamp AP. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 1995;22:65-95.
130. Baker GA, Marson AG. Cognitive and behavioural assessments in clinical trials: what type of measure? Epilepsy Res 2001;45:163-7.
131. Meador KJ. Can we treat cognitive deficits in patients with epilepsy? Epilepsy Behav 2001;2:307-8.
132. Fisher RS, Bortz JJ, Blum DE, Duncan B, Burke H. A pilot study of donepezil for memory problems in epilepsy. Epilepsy Behav 2001;2:330-4.
133. Moore JL, McAuley JW, Long L, Bornstein R. An evaluation of the effects of methylphenidate on outcomes in adult epilepsy patients. Epilepsy Behav 2002;3:92-5.
134. Langosch JM, Trimble MR. Epilepsy, psychosis and clozapine. Hum Psychopharmacol 2002;17:115-9.
135. McAuley JW, Long L, Heise J, et al. A prospective evaluation of the effects of a 12-week outpatient exercise program on clinical and behavioral outcomes in patients with epilepsy. Epilepsy Behav 2001;2:592-600.